Back to Search Start Over

FRBM Mini REVIEW: Chemogenetic approaches to probe redox dysregulation in heart failure.

Authors :
Guo, Ruby
Spyropoulos, Fotios
Michel, Thomas
Source :
Free Radical Biology & Medicine. May2024, Vol. 217, p173-178. 6p.
Publication Year :
2024

Abstract

Chemogenetics refers to experimental methods that use novel recombinant proteins that can be dynamically and uniquely regulated by specific biochemicals. Chemogenetic approaches allow the precise manipulation of cellular signaling to delineate the molecular pathways involved in both physiological and pathological disease states. Approaches utilizing yeast d -amino acid oxidase (DAAO) enable manipulation of intracellular redox metabolism through generation of hydrogen peroxide in the presence of d -amino acids and have led to the development of new and informative animal models to characterize the impact of oxidative stress in heart failure and neurodegeneration. These chemogenetic models, in which DAAO expression is regulated by different tissue-specific promoters, have led to a range of cardiac phenotypes. This review discusses chemogenetic approaches to manipulate oxidative stress in models of heart failure. These approaches provide new insights into the relationships between redox metabolism and normal and pathologic states in the heart, as well as in other diseases characterized by oxidative stress. [Display omitted] • Chemogenetic approaches can be used to study oxidant pathways involved in physiological and pathological disease states • Tissue-specific expression of D-amino acid oxidase (DAAO) has led to the development of new and informative animal models. • Chemogenetic/transgenic models of heart failure have furthered our insights into the effects of redox balance on the heart. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
08915849
Volume :
217
Database :
Academic Search Index
Journal :
Free Radical Biology & Medicine
Publication Type :
Academic Journal
Accession number :
176588190
Full Text :
https://doi.org/10.1016/j.freeradbiomed.2024.03.027